School of Mechanical Engineering, Purdue University, West Lafayette, Indiana, USA.
Mol Pharm. 2013 Jun 3;10(6):2111-26. doi: 10.1021/mp3005947. Epub 2013 Apr 9.
Nanomedicine for cancer, where nanoparticles (NPs) are used to deliver drugs, imaging agents, and heat to tumors, shows great potential of improved therapeutic outcomes. In spite of promising early stage results, its clinical efficacy is still significantly limited due to complex transport barriers in vivo. These transport barriers are associated with tumor microenvironment, which is highly complex and heterogeneous and varies spatiotemporally. Thus, in order to improve the in vivo efficacy of nanomedicine, NPs need to be designed and characterized considering their interaction with these complex transport barriers. In this article, thus, we discuss the multifaceted transport characteristics of NPs and their interaction mechanisms with the tumor microenvironment. We also illustrated that NPs have highly spatiotemporal and multiscale distribution around tumor. This dynamic and complex nature of NP transport needs to be taken into consideration in design strategies and evaluation criteria for successful delivery of cancer nanomedicine.
用于癌症的纳米医学,其中纳米粒子 (NPs) 用于向肿瘤递送药物、成像剂和热量,显示出改善治疗效果的巨大潜力。尽管早期阶段的结果很有希望,但由于体内复杂的传输障碍,其临床疗效仍然受到很大限制。这些传输障碍与肿瘤微环境有关,肿瘤微环境高度复杂且不均匀,并随时间和空间变化。因此,为了提高纳米医学的体内疗效,需要考虑 NPs 与其与这些复杂传输障碍的相互作用来设计和表征 NPs。因此,在本文中,我们讨论了 NPs 的多方面传输特性及其与肿瘤微环境的相互作用机制。我们还说明了 NPs 在肿瘤周围具有高度的时空和多尺度分布。在设计策略和评估癌症纳米医学成功传递的标准中,需要考虑 NP 传输的这种动态和复杂性质。